Back to Agenda
Session 5: Medical Information: Creating value Through Collaboration
Session Chair(s)
Isabelle C. Widmer, DrMed
CEO elytra GmbH, Consultant
elytra GmbH, Switzerland
Increasing regulatory and economic pressures on the life-science industry have led to changes in business and clinical practice. Many companies have adapted their business model accordingly, restructuring departments and implementing new and expanded job profiles in the process. Effective communication, collaboration and insight sharing across functions will be important for companies as they navigate the ever more complex healthcare landscape. This interactive session will focus on how Medical Information teams can add value for internal and external stakeholders through effective collaboration. We will explore the benefits of cooperating cross-functionally, as well as within Medical Affairs, for example with Medical Managers and Medical Science Liaisons. New opportunities for Medical Information teams in the emerging pharmaceutical landscape will be discussed.
Speaker(s)
Medical Affairs Collaboration
Isabelle C. Widmer, DrMed
elytra GmbH, Switzerland
CEO elytra GmbH, Consultant
Horizon Pharma, Dancing to the Beat of a New Drum
Tolu Taiwo, PharmD, MBA, FACMI
Horizon Pharma Inc, United States
Director, Medical Information
Have an account?